Skip to main content
Log in

Antineovascular effect of α-interferon on corneal neovascularization in rats

  • Original Article
  • Published:
Annals of Ophthalmology

Abstract

Clinical and histologic effects of topical recombinant α-interferon (IFN), systemic IFN, topical dexamethasone, and dexamethasone plus topical IFN on corneal neovascularization in response to silver nitrate cauterization were investigated in 110 eyes of 60 Wistar rats. The eyes were evaluated according to the burn stimulus, neovascularization, and histologic inflammation grades 5 days after cauterization. Antineovascular effects of topical and systemic IFN were significantly greater than a placebo but less than dexamethasone alone or in combination with IFN.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hoban BP, Collin HB. Effects of salicylate and steroid on neutrophil migration and corneal blood vessel growth. Am J Optom Physiol Optics. 1986;63:271–276.

    CAS  Google Scholar 

  2. Former CH, Klintworth GK. An evaluation of the role of leukocytes in the pathogenesis of experimentally induced corneal vascularization. Am J Pathol. 1975;79:537–550.

    Google Scholar 

  3. Former CH, Klintworth GK. An evaluation of the role of leukocytes in the pathogenesis of experimentally induced corneal vascularization. Am J Pathol. 1975;81:531–544.

    Google Scholar 

  4. Former CH, Klintworth GK. An evaluation of the role of leukocytes in the pathogenesis of experimentally induced corneal vascularization. Am J Pathol. 1976;82:157–170.

    Google Scholar 

  5. Mahoney JM, Waterbury LD. Drug effects on the neovascularization response to silver nitrate cauterization of the rat cornea. Curr Eye Res. 1985;4:531–535.

    PubMed  CAS  Google Scholar 

  6. Cooper CA, Micheal MD, Bergamini VW, Leopold IH. Use of flubiprofen to inhibit corneal neovascularization. Arch Ophthalmol. 1980;98:1102–1105.

    PubMed  CAS  Google Scholar 

  7. Phillips K, Arffa R, Cintron C, et al. Effects of prednisolone and medroxyprogesterone on corneal wound healing, ulceration and neovascularization. Arch Ophthalmol. 1983;101:640–643.

    PubMed  CAS  Google Scholar 

  8. Einhorn S, Blomgren H, Cantell K, Strander H. In vivo administration of interferon to man: studies on the immune system. Ann NY Acad Sci. 1980;350:580–582.

    Article  Google Scholar 

  9. Boye DB, Zetter BR. Inhibition of cell motility by interferon. Science. 1980;208:516–518.

    Article  Google Scholar 

  10. Saiki I, Dunegan MA, Fann AV, Koff WC. Regulatory effects on macrophages of human recombinant interferons. J Interferom Res. 1986;6:603–611.

    CAS  Google Scholar 

  11. Johnson HM, Smith BG, Baron S. Inhibition of the primary in vitro antibody by interferon preparations. J Immunol. 1975;114:403–407.

    PubMed  CAS  Google Scholar 

  12. Maeyer JD, Maeyer ED. Electrophoretically pure mouse interferon exerts multiple biological effects. Ann NY Acad Sci. 1980;350:347–353.

    Article  PubMed  Google Scholar 

  13. Miller JW, Stinson WG, Folkman J. Regression of experimental iris neovascularization with systemic alpha-interferon. Ophthalmology. 1993;100:9–14.

    PubMed  CAS  Google Scholar 

  14. Merigan TC. Human interferon as a therapeutic agent. N Engl J Med. 1988;18:1458–1460.

    Article  Google Scholar 

  15. Folkman J, Klagsburn M. Angiogenic factors. Science. 1987;235:442–447.

    Article  PubMed  CAS  Google Scholar 

  16. Suttorp SA, Cardozo N, Breedaart C, Kijlstra A. The fate of antigen-antibody complexes in the rabbit cornea. Curr Eye Res. 1991; 8:773–778.

    Google Scholar 

  17. Brodeur BR, Merigan TC. Suppressive effect of interferon on the humoral immune response to sheep red blood cells in mice. J Immunol. 1974;113:1319–1325.

    PubMed  CAS  Google Scholar 

  18. Baron S, Tyring SK, Fleischmann R, et al. The interferons: mechanisms of action and clinical applications. JAMA. 1991;266:1375–1383.

    Article  PubMed  CAS  Google Scholar 

  19. Grasser L, Maroger LM, Jeans YD, Guillon V, Tovey G. Interferon-induced disease in mice and rats. Ann NY Acad Sci. 1980;350:12–20.

    Article  Google Scholar 

  20. Sidky YA, Borden EC. Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. Cancer Res. 1987;47:5155–5161.

    PubMed  CAS  Google Scholar 

  21. White CW, Sondheimer HM, Crouch EC. Treatment of pulmonary heman giomatosis with recombinant interferon alpha-2a. N Engl J Med. 1989;320:1197–1200.

    Article  PubMed  CAS  Google Scholar 

  22. Chan CK, Kempin SJ, Noble SK, Palmer GA. The treatment of choroidal neovascular membranes by alpha interferon. Ophthalmology 1994;101:289–300.

    PubMed  CAS  Google Scholar 

  23. Park WC, Shin DH. Regression of experimental corneal vascularization with subconjunctival injection of interferon α-2a. Invest Ophthalmol Vis Sci. 1994;35:1351.

    Google Scholar 

  24. Nguyen N, Goldberg M, Pico J, Kim W, Abbot RL, Levy B. Topical and subcutaneous alpha-interferon falls to suppress corneal neovascularization. Cornea. 1995;14:147–151.

    Article  PubMed  CAS  Google Scholar 

  25. Pharmacological Therapy for Macular Degeneration Study Group. Interferon alpha-2a is ineffective for patients with choroidal neovascularization secondary to age-related macular degeneration. Arch Ophthalmol. 1997;115:865–872.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Öztürk, F., Sobaci, G., Sami Ilker, S. et al. Antineovascular effect of α-interferon on corneal neovascularization in rats. Ann Ophthalmol 33, 35–39 (2001). https://doi.org/10.1007/s12009-001-0070-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12009-001-0070-5

Keywords

Navigation